Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Rani Therapeutics Holdings IncClass A Common Stock stock

Learn how to easily invest in Rani Therapeutics Holdings IncClass A Common Stock stock.

Rani Therapeutics Holdings Inc. Class A Common Stock is a biotechnology business based in the US. Rani Therapeutics Holdings IncClass A Common Stock shares (RANI) are listed on the NASDAQ and all prices are listed in US Dollars. Rani Therapeutics Holdings IncClass A Common Stock employs 91 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Rani Therapeutics Holdings IncClass A Common Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RANI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Rani Therapeutics Holdings IncClass A Common Stock stock price (NASDAQ: RANI)

Use our graph to track the performance of RANI stocks over time.

Rani Therapeutics Holdings IncClass A Common Stock shares at a glance

Information last updated 2022-01-16.
Latest market close$18.88
52-week range$9.24 - $36.27
50-day moving average $22.81
200-day moving average $20.31
Wall St. target price$28.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.01

Buy Rani Therapeutics Holdings IncClass A Common Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Stocks
$0
0%
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Rani Therapeutics Holdings IncClass A Common Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Rani Therapeutics Holdings IncClass A Common Stock price performance over time

Historical closes compared with the close of $18.88 from 2022-01-21

1 week (2022-01-13) -3.48%
1 month (2021-12-18) N/A
3 months (2021-10-22) 1.94%
6 months (2021-07-18) N/A
1 year (2021-01-18) N/A
2 years (2020-01-18) N/A
3 years (2019-01-18) N/A
5 years (2017-01-18) N/A

Rani Therapeutics Holdings IncClass A Common Stock financials

Revenue TTM $2.9 million
Gross profit TTM $462,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $2.61
Market capitalisation $407.4 million

TTM: trailing 12 months

Rani Therapeutics Holdings IncClass A Common Stock share dividends

We're not expecting Rani Therapeutics Holdings IncClass A Common Stock to pay a dividend over the next 12 months.

Rani Therapeutics Holdings IncClass A Common Stock overview

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-103, a glucagon-like peptide-1 mimetic to treat type 2 diabetes; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California. .

Frequently asked questions

What percentage of Rani Therapeutics Holdings IncClass A Common Stock is owned by insiders or institutions?
Currently 63.186% of Rani Therapeutics Holdings IncClass A Common Stock shares are held by insiders and 3.904% by institutions.
How many people work for Rani Therapeutics Holdings IncClass A Common Stock?
Latest data suggests 91 work at Rani Therapeutics Holdings IncClass A Common Stock.
When does the fiscal year end for Rani Therapeutics Holdings IncClass A Common Stock?
Rani Therapeutics Holdings IncClass A Common Stock's fiscal year ends in December.
Where is Rani Therapeutics Holdings IncClass A Common Stock based?
Rani Therapeutics Holdings IncClass A Common Stock's address is: 2051 Ringwood Avenue, San Jose, CA, United States, 95131
What is Rani Therapeutics Holdings IncClass A Common Stock's ISIN number?
Rani Therapeutics Holdings IncClass A Common Stock's international securities identification number is: US7530181004

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site